A Neural Network-Based Identification of Developmentally Competent or Incompetent Mouse Fully-Grown Oocytes
March 3rd, 2018
6.3K views
Here, we present a protocol for non-invasive assessment of oocyte developmental competence performed during their in vitro maturation from the germinal vesicle to the metaphase II stage. This method combines time-lapse imaging with particle image velocimetry (PIV) and neural network analyses.
Overview
This article presents a non-invasive protocol for assessing oocyte developmental competence during in vitro maturation. The method utilizes time-lapse imaging and particle image velocimetry (PIV) combined with neural network analyses.
Key Study Components
Area of Science
- Reproductive Biology
- Oocyte Development
- In Vitro Fertilization
Background
- Infertility affects approximately 20% of couples.
- One-third of women undergoing cancer treatment risk premature ovarian failure.
- Identifying oocytes with developmental capacity is crucial for improving fertility treatments.
- This study focuses on mouse oocytes transitioning from germinal vesicle to metaphase II.
Purpose of Study
- To identify oocytes with developmental competence using a non-invasive method.
- To evaluate female gamete potential through observation of oocyte movements.
- To correlate plasmic movement profiles with developmental competence.
Methods Used
- Time-lapse imaging to monitor oocyte movements.
- Particle image velocimetry (PIV) for analyzing movement patterns.
- Neural network analysis to interpret data.
- Comparison of movement profiles between competent and incompetent oocytes.
Main Results
- Oocytes display distinct movement profiles correlated with their developmental competence.
- The non-invasive method allows for real-time assessment of oocyte quality.
- Findings may enhance fertility treatment strategies.
- Potential implications for improving outcomes in assisted reproductive technologies.
Conclusions
- The study demonstrates a reliable non-invasive approach to assess oocyte quality.
- Time-lapse imaging and PIV can effectively predict developmental competence.
- This method may contribute to advancements in reproductive medicine.
Frequently Asked Questions
What is the significance of assessing oocyte developmental competence?
Assessing oocyte developmental competence is crucial for improving fertility treatments and outcomes in assisted reproductive technologies.
How does the non-invasive method work?
The method uses time-lapse imaging to observe oocyte movements, which are analyzed using particle image velocimetry and neural networks.
What are the potential applications of this research?
This research may enhance fertility treatment strategies and improve outcomes for women undergoing assisted reproductive technologies.
What are the main advantages of this technique?
The main advantage is the ability to evaluate oocyte quality without invasive procedures, allowing for real-time assessments.
What type of oocytes were studied in this research?
The study focused on mouse oocytes transitioning from the germinal vesicle to the metaphase II stage.
How prevalent is infertility among couples?
Infertility affects about 20% of couples, highlighting the importance of research in this area.
Executive Industry Relevance
Assessing oocyte developmental competence non-invasively addresses a critical bottleneck in assisted reproductive technologies by enabling early selection of viable gametes. This approach supports predictive confidence in fertility treatment pipelines by correlating cytoplasmic movement profiles with developmental outcomes. The method’s adaptability to human oocytes offers translational value for improving IVF success rates and reducing clinical trial attrition in reproductive medicine.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of developmental competence as a phenotypic readout for oocyte quality assessment.
- Operational Value: Provides a non-invasive, imaging-based proxy for functional validation without requiring fertilization or embryo culture.
Screening & Assay Development
- Scientific Value: Generates quantitative cytoplasmic movement velocity profiles as measurable outputs for high-content screening.
- Operational Value: Standardizes time-lapse imaging and PIV analysis for reproducible, scalable oocyte evaluation across laboratories.
Translational & Preclinical Research
- Scientific Value: Supports disease-relevant system modeling by linking oocyte movement dynamics to developmental competence in mammalian systems.
- Operational Value: Facilitates preclinical continuity from discovery to validation through consistent, non-invasive readouts applicable to human oocytes.
Pipeline & Workflow Integration
The method integrates into early discovery workflows by providing a predictive assay for oocyte quality prior to fertilization, enabling go/no-go decisions in gamete selection pipelines.
- Discovery Biology: Supports hypothesis testing of cytoplasmic dynamics as biomarkers of developmental potential.
- Screening: Delivers standardized, quantitative velocity metrics for automated oocyte classification.
- Analytics: Employs feed-forward neural networks to convert time-lapse movement data into competence probability scores.
- Translational Research: Connects mouse oocyte findings to human applications through conserved mechanisms of cytoplasmic regulation during maturation.
- Enterprise Reuse: Establishes a reusable imaging and analysis platform for oocyte quality assessment across species and clinical settings.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in oocyte selection by linking movement patterns to developmental outcomes with 91.03% accuracy.
- Operational Value: Ensures reproducibility through standardized time-lapse intervals, PIV processing, and neural network training protocols.
- Strategic Value: Improves capital efficiency by reducing reliance on invasive assays and failed IVF cycles through pre-selection of competent oocytes.
- Portfolio Impact: Enables risk-adjusted prioritization of oocytes in ART workflows, increasing the likelihood of successful embryo development.
Implementation Considerations
- Requires expertise in time-lapse microscopy, particle image velocimetry, and neural network training.
- Dependent on controlled incubation systems maintaining 37°C and 5% CO₂ for consistent oocyte maturation.
- Necessitates standardized image acquisition at 8-minute intervals over 15 hours for reliable cytoplasmic movement profiling.
- Involves manual oocyte perimeter delimitation in CellPave software, which may introduce inter-operator variability.
- Limited to species with observable cytoplasmic movements during in vitro maturation; applicability to humans requires validation.
Biopharma FAQs
Why does cytoplasmic movement velocity profiling matter for oocyte competence assessment?
Cytoplasmic movement velocity profiling provides a quantitative, non-invasive readout that correlates with developmental competence, enabling objective classification of oocytes based on functional dynamics rather than morphology alone.
How does isolating cytoplasmic movement as an independent variable support discovery pipeline decisions?
By isolating cytoplasmic movement velocity as the key independent variable, the method reduces confounding factors and enables direct correlation with developmental outcomes, improving target validation confidence in oocyte quality assays.
What do quantitative cytoplasmic movement measurements enable in terms of predictive modeling?
Quantitative cytoplasmic movement measurements serve as input features for the feed-forward artificial neural network, allowing the system to predict competence probability with 91.03% accuracy based on temporal movement patterns.
Why are replication requirements important for cross-functional collaboration in oocyte assessment workflows?
Replication across 10-fold cross-validation ensures the neural network’s robustness and generalizability, allowing consistent performance when shared between research, clinical, and ART laboratory teams.
What statistical analysis capabilities are required before implementing this oocyte classification method?
Implementation requires competence in time-lapse image analysis, particle image velocimetry for velocity vector extraction, and training/testing of feed-forward neural networks to interpret movement profiles as predictive inputs.
